Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoplasm Metastasis × Imiquimod × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 21 Carcinoma, Basal Cell 10 Uterine Cervical Dysplasia 7 Melanoma 6 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Precancerous Conditions 3 Glioblastoma 3 Condylomata Acuminata 3 Urinary Bladder Neoplasms 2 Squamous Intraepithelial Lesions 2 Papillomavirus Infections 2 Non-Muscle Invasive Bladder Neoplasms 2 Keratosis 2 Hutchinson's Melanotic Freckle 2 HIV Infections 2 Glioma 2 Astrocytoma 2 Warts 1 Vulvar Neoplasms 1 Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1 Virus Diseases 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sialorrhea 1 Sexually Transmitted Diseases 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Patient Satisfaction 1

Interventions

Gemcitabine 62 Capecitabine 57 Paclitaxel 53 Fluorouracil 51 Oxaliplatin 50 Bevacizumab 48 Leucovorin 44 Docetaxel 41 Nivolumab 38 Carboplatin 35 Cisplatin 34 Irinotecan 33 pembrolizumab 28 Cetuximab 28 Trastuzumab 27 Radiosurgery 26 Radiotherapy 23 Everolimus 21 Sorafenib 18 Pemetrexed 17 Panitumumab 17 Cyclophosphamide 17 Prednisone 16 Ipilimumab 16 Erlotinib Hydrochloride 16 Doxorubicin 16 Albumin-Bound Paclitaxel 16 Lapatinib 15 Zoledronic Acid 14 pazopanib 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02234921 2018-10-11

DRibble

UbiVac

Phase 1 Completed

Adenocarcinoma, Neoplasm Metastasis, Sialorrhea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡